Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component.
about
Prospects for vaccine prevention of meningococcal infectionBaseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccineUse of a molecular decoy to segregate transport from antigenicity in the FrpB iron transporter from Neisseria meningitidisAn OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and ToxicityMolecular epidemiology of Neisseria meningitidis serogroup B in BrazilAgdbNet - antigen sequence database software for bacterial typing.Typing Clostridium difficile strains based on tandem repeat sequences.Meningococcus genome informatics platform: a system for analyzing multilocus sequence typing data.Review of meningococcal group B vaccines.The battle for iron between bacterial pathogens and their vertebrate hosts.Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines.Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing.Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.Microbe-host interactions: structure and role of Gram-negative bacterial porinsPersistence of hyperinvasive meningococcal strain types during global spread as recorded in the PubMLST database.Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989.Phenotypic and genotypic characteristics of Neisseria meningitidis disease-causing strains in Argentina, 2010.Neisseria meningitidis porA, fetA and fHbp gene distribution in Western Australia 2000 to 2011.Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.Rapid genetic grouping of factor h-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidate.Molecular targets in meningococci: efficient routine characterization and optimal outbreak investigation in conjunction with routine surveillance of the meningococcal group B vaccine candidate, fHBPMolecular characterization of invasive Neisseria meningitidis strains isolated in Chile during 2010-2011Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine.Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013-14Antigen sequence typing of outer membrane protein (fetA) gene of Neisseria meningitidis serogroup A from Delhi & adjoining areas.Evidence for indirect nosocomial transmission of Neisseria meningitidis resulting in two cases of invasive meningococcal diseaseA gene-by-gene population genomics platform: de novo assembly, annotation and genealogical analysis of 108 representative Neisseria meningitidis genomesCluster of serogroup W-135 meningococcal disease in 3 military recruits.The iron-repressed, AraC-like regulator MpeR activates expression of fetA in Neisseria gonorrhoeaeSequence Type 4821 Clonal Complex Serogroup B Neisseria meningitidis in China, 1978-2013.IS1301 fingerprint analysis of Neisseria meningitidis strains belonging to the ET-15 clone.Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets.Bacteremia in an immunocompromised patient caused by a commensal Neisseria meningitidis strain harboring the capsule null locus (cnl).Refolding, purification and crystallization of the FrpB outer membrane iron transporter from Neisseria meningitidisDeletion of fetA gene sequences in serogroup B and C Neisseria meningitidis isolatesChanges in Meningococcal Strains in the Era of a Serogroup C Vaccination Campaign: Trends and Evolution in Belgium during the Period 1997-2012.Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany.Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.
P2860
Q24537338-239B3E0C-3232-42A3-AB0B-A336712313FFQ24629949-80480B67-37F7-4248-B59B-907660FC5AB7Q27676685-4543B923-7DD0-4C4C-AA75-3DD8F4DB7320Q28607442-C61AFC97-E609-4D8A-8A90-D384CECBA22CQ28731309-F0F3AC69-8425-4238-9658-4BE43AAE19A6Q33247489-6B1EC63F-D899-4569-AC53-3AAD0AEF5F7DQ33398660-A6DC1E6E-E813-457D-A705-F17E4661C5D5Q33452430-61D79E29-E375-4D17-9ABF-8AC8387C32D1Q33646965-E4930522-CE32-4C94-99BA-4D5571664813Q33658687-36E5BD09-B6B5-4DFF-A8BE-725CB9DE9F5DQ33729202-D73318F4-BD85-435E-B0F0-005598D6D2C5Q33913048-58C06071-9D1E-48D2-8174-9C0B90955F47Q34108549-9FDD6E32-4F7A-4242-AA88-633BE0A30C24Q34113328-98D00BCE-4FBA-41A6-8F8C-87ED108E3853Q34321941-9868AB96-1408-4268-B1E5-676B84284740Q34428829-41D591A2-77A7-4D3C-95E9-809D10C1013DQ34430626-07C6CC1C-1AD1-4C3B-815C-C36A89D28104Q34431744-ED9C9A53-A587-4B61-B60A-BE456FDBAC1CQ34618580-5F612ADF-3BF6-4B74-8527-1A032029768BQ34700648-D59F1F20-4119-4914-9D45-E855F2E39CA3Q34707962-B3E5F93B-1BA2-417C-A06C-3DF08B7B184DQ34720425-B6EAAE3D-6E34-4E5A-AFA0-7BAB4698B43EQ34738737-2EF2A3B4-2F17-4EC8-8105-8405394F380CQ34776133-BF0E82D8-B403-4F7E-8E1A-3AFA6A3D6113Q34892719-6E8F98C3-B95E-4B1C-B2FA-BA60A459017DQ35064842-3FA3D1D2-ACA0-4805-9B99-1CED2285AC1FQ35193608-F3929C36-3C14-45A5-883D-98BAFEF98541Q35220802-D03FA7A8-3187-415B-BF79-2B5E076C5671Q35530102-3BDE63B3-31FF-47E6-9BB4-89A1ECB57129Q35553762-5FCC06DE-3569-427D-93F7-B697B229B454Q35598127-624AE083-264D-4DF4-B9DD-6385AB26F353Q35673367-B9EE45E3-62AB-49CA-8CB4-D662BFDAC615Q35690291-F86B2CFC-0AC1-44AB-B19D-EDB0F58B974BQ35708801-B96C55E8-29C5-47EA-9088-1F4AEAF6F7DBQ35714421-0BCE59C9-849D-4D7A-AB0B-281285BE6C52Q35742066-D845174F-8602-47C5-B857-09D806910695Q35784238-DA25F336-A836-438D-B6C2-187980766F4EQ35794798-A2E22607-815F-4144-B97E-E3BC6DC7EF67Q35877401-DBA12F17-D7DB-4B8D-B7ED-45C47C2DEB79Q35912710-44CBBD70-945B-44FB-9CE6-74A7C7D07AFA
P2860
Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component.
@en
Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component.
@nl
type
label
Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component.
@en
Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component.
@nl
prefLabel
Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component.
@en
Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component.
@nl
P356
P1433
P1476
Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component.
@en
P2093
Emily A L Thompson
Ian M Feavers
P304
P356
10.1099/MIC.0.26131-0
P577
2003-07-01T00:00:00Z